Drug Management of Fetal Tachyarrhythmias: Are We Ready for a Systematic and Evidence-Based Approach?

Fetal tachyarrhythmias are a life‐threatening condition complicating a small proportion of normal pregnancies. Despite major advances in the (intrauterine) pharmacologic treatment of these arrhythmias over the last years major uncertainties remain. Among these are controversies in the choice of agen...

Full description

Saved in:
Bibliographic Details
Published in:Pacing and clinical electrophysiology 2008-02, Vol.31 (s1), p.S54-S57
Main Authors: VAN DEN HEUVEL, FREEK, BINK-BOELKENS, MARGREET Th.E., SARVAAS, GIDEON J. DU MARCHIE, BERGER, ROLF M.F.
Format: Article
Language:English
Subjects:
Anti-Arrhythmia Agents - administration & dosage
Clinical Trials as Topic
drug management
Evidence-Based Medicine
Female
fetal cardiology
Fetal Diseases - diagnosis
Fetal Diseases - therapy
Humans
Pregnancy
tachyarrhythmias
Tachycardia, Ventricular - diagnosis
Tachycardia, Ventricular - embryology
Tachycardia, Ventricular - therapy
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Fetal tachyarrhythmias are a life‐threatening condition complicating a small proportion of normal pregnancies. Despite major advances in the (intrauterine) pharmacologic treatment of these arrhythmias over the last years major uncertainties remain. Among these are controversies in the choice of agents in relation to arrhythmia type, and timing and duration of treatment. Currently, no evidence‐based approach to the management of fetal tachyarrhythmias is available. An international registry is proposed as an important step toward obtaining the necessary data to develop evidence‐based management strategies.
ISSN:0147-8389
1540-8159
DOI:10.1111/j.1540-8159.2008.00958.x